Paper · 41555834
Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-naïve individuals with diabetes: A target trial emulation.
Tatewaki T and 3 others. Diabetes Obes Metab, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-naïve individuals with diabetes: A target trial emulation. Papers, record 41555834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41555834
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-naïve individuals with diabetes: A target trial emulation.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dipeptidyl-Peptidase IV Inhibitors | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Pancreatitis | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hypoglycemic Agents | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Aged | |
| Japan | |
| Acute Disease | |
| Adult | |
| Incidence | |
| Risk Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024-YNG-031 | Japan Association for Diabetes Education and Care | PubMed | ||
| 23AA2003 | Ministry of Health, Labour and Welfare | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,736,555 | Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. | BMJ | 2014 | https://conductscience.org/library/papers/24736555 | PubMed |
| 2 | 23,992,602 | Alogliptin after acute coronary syndrome in patients with type 2 diabetes. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23992602 | PubMed |
| 3 | 27,479,930 | Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. | JAMA Intern Med | 2016 | https://conductscience.org/library/papers/27479930 | PubMed |
| 4 | 31,431,452 | Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors. | Diabetes Care | 2019 | https://conductscience.org/library/papers/31431452 | PubMed |
| 5 | 25,851,403 | Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan. | Pharmacoepidemiol Drug Saf | 2015 | https://conductscience.org/library/papers/25851403 | PubMed |
| 6 | 18,784,098 | Assessing the cardiovascular safety of diabetes therapies. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18784098 | PubMed |
| 7 | 20,012,329 | Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. | J Hepatobiliary Pancreat Sci | 2010 | https://conductscience.org/library/papers/20012329 | PubMed |
| 8 | 32,409,278 | Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016. | Pancreatology | 2020 | https://conductscience.org/library/papers/32409278 | PubMed |
| 9 | 32,017,292 | Pancreatic safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. | Pharmacoepidemiol Drug Saf | 2020 | https://conductscience.org/library/papers/32017292 | PubMed |
| 10 | 32,369,102 | Overlap Weighting: A Propensity Score Method That Mimics Attributes of a Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/32369102 | PubMed |
1 to 10 of 38
See all 38 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41555834
GET https://conductscience.org/api/papers/v1/41555834/references?page=2